Tomer Kariv, Director at Arno Therapeutics, Inc (ARNI), bought 2,896,124 shares at $0.35 ($1.0M) on 2016-01-12, disclosed to the SEC on 2016-01-14.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.35 | 206,986 | $72K | 7.1% |
| 2 | $0.35 | 206,986 | $72K | 7.1% |
| 3 | $0.35 | 533,208 | $187K | 18.4% |
| 4 | $0.35 | 533,208 | $187K | 18.4% |
| 5 | $0.35 | 707,868 | $248K | 24.4% |
| 6 | $0.35 | 707,868 |
| $248K |
| 24.4% |
| Total | $0.35 avg | 2,896,124 | $1.0M | 100% |
| Filing → |
| ELOX | BUY | 2019-06-26 | $1.8M | — | Filing → |
| VBIV | BUY | 2018-12-18 | $4.0M | — | Filing → |
| LOGC | BUY | 2018-10-25 | $4.2M | — | Filing → |